v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
ASSETS    
Cash and due from banks $ 115,949 $ 173,533
Restricted cash 0 2,459
Federal funds sold 1,851 838
Securities available for sale, at fair value 332,928 312,035
Restricted equity investments 19,016 19,275
Other equity investments 4,910 4,834
Other investments 20,781 19,405
Loans held for sale 14,769 30,976
Loans held for investment, net of deferred fees and costs 1,865,717 2,111,797
Less: allowance for credit losses (19,444) (23,023)
Loans held for investment, net 1,846,273 2,088,774
Accrued interest receivable 10,787 12,537
Other real estate owned 1,683 279
Premises and equipment, net 21,549 21,394
Right-of-use assets 6,637 7,962
Other intangible assets 2,642 3,859
Deferred tax asset, net 22,721 27,312
Other assets 10,093 11,788
Total assets 2,432,589 2,737,260
Deposits:    
Noninterest-bearing demand 398,541 452,690
Interest-bearing demand and money market 612,648 598,875
Savings 100,346 100,857
Time 799,627 1,027,020
Total deposits 1,911,162 2,179,442
FHLB borrowings 150,000 150,000
Subordinated notes, net 14,716 39,789
Lease liabilities 7,233 8,613
Other liabilities 25,787 31,628
Total liabilities 2,108,898 2,409,472
Commitments and contingencies (Note 19)
Stockholders’ Equity:    
Common stock, no par value; 150,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively; and 91,475,278 and 84,972,610 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively 331,917 322,791
Additional paid-in capital 23,552 29,687
(Accumulated deficit) retained earnings (659) 17,772
Accumulated other comprehensive loss, net of tax (31,119) (42,462)
Total stockholders’ equity 323,691 327,788
Total liabilities and stockholders’ equity $ 2,432,589 $ 2,737,260